Snehangshu Kundu

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Journal: British journal of haematology

Published: May 19, 2025

NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors.

NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: December 08, 2024

Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib.

Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib.

Journal: EBioMedicine

Published: February 06, 2024

Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells.

Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells.

Journal: Cell communication and signaling : CCS

Published: August 25, 2023

Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions.

Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions.

Journal: Cancers

Published: June 11, 2022

Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity.

Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity.

Journal: Biochemical pharmacology

Published: May 24, 2022

Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis.

Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 21, 2021

Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer.

Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer.

Journal: Scientific reports

Published: April 03, 2020

Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression.

Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression.

Journal: Clinical epigenetics

Published: May 28, 2019

Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.

Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.

Journal: Genome medicine

Published: August 18, 2017

Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth.

Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth.

Journal: Oncotarget

Published: May 27, 2017

Genome-wide identification of physically clustered genes suggests chromatin-level co-regulation in male reproductive development in Arabidopsis thaliana.

Genome-wide identification of physically clustered genes suggests chromatin-level co-regulation in male reproductive development in Arabidopsis thaliana.

Journal: Nucleic acids research

Published: January 11, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026